Page last updated: 2024-10-15

ed 110

Description

ED 110: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID135705573
MeSH IDM0211303

Synonyms (10)

Synonym
139112-73-5
ed 110
j-109384
5h-indolo(2,3-a)pyrrolo(3,4-c)carbazole-5,7(6h)-dione, 12,13-dihydro-1,11-dihydroxy-12-beta-d-glucopyranosyl-
12-beta-d-glucopyranosyl-12,13-dihydro-1,11-dihydroxy-5h-indolo(2,3-a)pyrrolo(3,4-c)carbazole-5,7(6h)-dione
12,13-dihydro-1,11-dihydroxy-12-beta-d-glucopyranosyl-5h-indolo(2,3-a)pyrrolo(3,4-c)carbazole-5,7(6h)-dione
j 109384
ed-110
1,5-anhydro-1-(7-hydroxy-1,3,10-trioxo-2,3,8,9,10,12-hexahydro-1h-indolo[2,3-a]pyrrolo[3,4-c]carbazol-9-yl)hexitol
DTXSID90930362
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's4 (66.67)18.2507
2000's1 (16.67)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]